United States · Platforms & data · Finviz

Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026

Published by Finviz · United States 3 d ago

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially…

Read the full article on Finviz Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finviz.com)

Also worth reading

The Motley Fool

Earnings call transcript: Preferred Bank tops Q3 2026 EPS, shares slip premarket

Benzinga

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Yahoo Finance

Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026

Share

Also worth reading

Rogers Communications: 3 Key Takeaways for Long-Term Investors

Trump prepares tariff relief on Canada ahead of midterms - report

Think annuities are a rip-off? Now might be the perfect time to reconsider.

Earnings call transcript: Preferred Bank tops Q3 2026 EPS, shares slip premarket

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Amazon's $197 waterproof resin storage cabinet has 2 cabinets and a drawer